Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

Clinical trial NCT05768880 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05768880
Sponsor: Seattle Children's Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma Diffuse Midline Glioma Recurrent CNS Tumor, Adult Recurrent, CNS Tumor, Childhood Refractory Primary Malignant Central Nervous System Neoplasm

Start date: 2023-05-05
Primary completion: 2028-01-15
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.